Alzheimer’s Disease – CMA Clinical Spotlight, by Dr Amrita Singh. This article is valued at one hour of CMA CPD. Please see the Reflective Practice section at the end of this article to complete your CPD activity and instructions on how to upload this to your CPD log on the CMA site.
Alzheimer’s disease is a progressive neurodegenerative disorder that primarily affects memory, thinking, and behaviour. It is the most common cause of dementia, a group of conditions characterised by a decline in cognitive function severe enough to interfere with daily life and independence (NHS, 2024).
The condition develops gradually as brain cells become damaged and die over time. This leads to a progressive decline in abilities such as memory, reasoning, language, and problem-solving. Early symptoms often include mild forgetfulness, but as the disease advances, individuals may experience significant difficulties with communication, recognition of familiar people, and performing routine tasks (Mayo Clinic, 2024).
Alzheimer’s disease is associated with abnormal changes in the brain, including the buildup of amyloid plaques and tau tangles, which interfere with normal communication between brain cells and contribute to their degeneration (Kumar et al., 2024).
Although Alzheimer’s disease mainly affects older adults, it is not a normal part of ageing. The progression varies between individuals, but over time it leads to increasing dependence on others for care and support (Alzheimer’s Association, 2025).
Causes of Alzheimer’s Disease
The exact cause of Alzheimer’s disease is not fully understood, but it is believed to result from a combination of genetic, biological, and environmental factors that affect the brain over time. These factors contribute to the progressive damage and loss of brain cells (NHS, 2024).
One of the key biological features associated with Alzheimer’s disease is the accumulation of abnormal proteins in the brain, including amyloid plaques and tau tangles. These changes disrupt communication between nerve cells, impair their function, and eventually lead to cell death (Kumar et al., 2024).
Age is the most significant risk factor, with the likelihood of developing Alzheimer’s disease increasing as individuals grow older. Although the condition is not a normal part of ageing, advancing age increases vulnerability to the biological changes associated with the disease (Mayo Clinic, 2024).
Genetic factors may also play a role, particularly in early-onset Alzheimer’s disease, which is less common but strongly linked to inherited gene mutations. In late-onset Alzheimer’s disease, certain genes may increase susceptibility, although they do not guarantee that the condition will develop (Alzheimer’s Association, 2025).
Other contributing factors may include cardiovascular health, lifestyle factors, and overall brain health. Conditions such as high blood pressure, diabetes, obesity, and smoking may increase the risk of cognitive decline and Alzheimer’s disease (Cleveland Clinic, 2022).
Signs and symptoms of Alzheimer’s Disease
The signs and symptoms of Alzheimer’s disease develop gradually and worsen over time as brain function declines. Early symptoms are often subtle and may be mistaken for normal ageing, but they progressively interfere with daily life and independence (NHS, 2024).
One of the earliest and most common symptoms is memory loss, particularly difficulty remembering recent events, conversations, or newly learned information. Individuals may repeatedly ask the same questions or forget important dates and appointments (Mayo Clinic, 2024).
As the condition progresses, individuals may experience difficulty with thinking and reasoning, including problems with planning, decision-making, and problem-solving. Tasks that were once routine, such as managing finances or following instructions, may become increasingly challenging (Alzheimer’s Association, 2025).
Language and communication difficulties are also common. Individuals may struggle to find the right words, follow conversations, or express themselves clearly. They may pause frequently or substitute incorrect words (Cleveland Clinic, 2022).
Changes in behaviour and personality may occur, including confusion, irritability, mood swings, anxiety, or withdrawal from social activities. Some individuals may also experience disorientation, becoming lost in familiar places or having difficulty recognising familiar people (Kumar et al., 2024).
In later stages, symptoms become more severe and may include significant memory loss, inability to perform daily activities, difficulty swallowing, and loss of physical coordination. Individuals often require full-time care and support at this stage (NHS, 2024).
Risk factors for Alzheimer’s Disease
Several factors are associated with an increased risk of developing Alzheimer’s disease, although having one or more risk factors does not necessarily mean that the condition will occur. These factors reflect a combination of genetic, biological, and lifestyle influences on brain health (NHS, 2024).
The most significant risk factor is age. The likelihood of developing Alzheimer’s disease increases markedly after the age of 65, although it is not a normal part of ageing (Mayo Clinic, 2024).
A family history of Alzheimer’s disease may also increase risk. Individuals with close relatives affected by the condition may have a higher likelihood of developing it, particularly if there are inherited genetic mutations involved. Certain genes are associated with increased susceptibility, although they do not guarantee disease development (Alzheimer’s Association, 2025).
Genetic factors play a stronger role in early-onset Alzheimer’s disease, which is less common but often linked to specific inherited gene mutations (Kumar et al., 2024).
Cardiovascular and metabolic conditions are also important risk factors. These include high blood pressure, diabetes, high cholesterol, obesity, and smoking, all of which may contribute to reduced blood flow to the brain and increased risk of cognitive decline (Cleveland Clinic, 2022).
Lifestyle factors such as physical inactivity, poor diet, low levels of mental stimulation, and social isolation may further increase risk. Maintaining an active and engaged lifestyle is associated with better cognitive health over time (NHS, 2024).
Stages of Alzheimer’s Disease
Alzheimer’s disease typically progresses gradually and is commonly described in three main stages: early (mild), middle (moderate), and late (severe). Each stage reflects increasing levels of cognitive decline and functional impairment (NHS, 2024).
1. Early stage (mild Alzheimer’s disease)
In the early stage, symptoms are often subtle and may be mistaken for normal ageing. Individuals may experience mild memory loss, difficulty recalling recent events, or trouble finding the right words. They may also have slight challenges with planning, organisation, or completing familiar tasks, but can usually continue to function independently (Mayo Clinic, 2024).
2. Middle stage (moderate Alzheimer’s disease)
This stage is typically the longest phase and is marked by more noticeable cognitive and behavioural changes. Individuals may experience increased memory loss, confusion, difficulty recognising familiar people, and problems with language and communication. Daily activities such as dressing, personal hygiene, and meal preparation may require assistance. Mood changes, irritability, and wandering may also occur (Alzheimer’s Association, 2025).
3. Late stage (severe Alzheimer’s disease)
In the advanced stage, individuals experience severe cognitive decline and loss of physical functioning. They may lose the ability to communicate clearly, recognise loved ones, or perform basic activities such as eating or walking. Individuals often require full-time care and support, as the disease affects both mental and physical capabilities (Kumar et al., 2024).
The rate of progression varies between individuals, but Alzheimer’s disease is a progressive condition, meaning symptoms worsen over time. Early recognition and supportive care can help manage symptoms and improve quality of life.
Complications of Alzheimer’s disease
As Alzheimer’s disease progresses, it can lead to a range of complications that affect both physical health and overall functioning. These complications arise due to the gradual decline in cognitive abilities, loss of independence, and increasing physical impairment (NHS, 2024).
One of the most significant complications is the inability to perform daily activities. Individuals may struggle with basic tasks such as eating, dressing, bathing, and managing personal hygiene, leading to increased dependence on caregivers (Mayo Clinic, 2024).
Alzheimer’s disease can also result in communication difficulties, making it harder for individuals to express needs, discomfort, or pain. This may lead to unmet needs and increased risk of distress or behavioural changes (Alzheimer’s Association, 2025).
As the condition advances, individuals may develop difficulty swallowing (dysphagia), which increases the risk of choking and aspiration. This can lead to respiratory infections such as pneumonia, a common and serious complication in the later stages of the disease (Kumar et al., 2024).
Reduced mobility and prolonged periods of inactivity may contribute to muscle weakness, falls, and pressure sores, further affecting physical health and quality of life (Cleveland Clinic, 2022).
In addition, individuals may experience behavioural and psychological symptoms, including agitation, anxiety, depression, and sleep disturbances. These symptoms can impact both the individual and their caregivers (NHS, 2024).
Prognosis of Alzheimer’s disease
The prognosis of Alzheimer’s disease is generally progressive and long-term, as the condition gradually worsens over time. Alzheimer’s disease is currently not curable, and the focus of care is on managing symptoms, supporting quality of life, and slowing functional decline where possible (NHS, 2024).
The rate of progression varies between individuals. On average, people may live several years after diagnosis, although this can differ depending on age at onset, overall health, and the presence of other medical conditions (Mayo Clinic, 2024).
In the early stages, individuals may remain relatively independent with mild memory and cognitive difficulties. As the disease advances, there is a gradual loss of the ability to perform daily activities, communicate effectively, and maintain physical independence (Alzheimer’s Association, 2025).
In the later stages, individuals often require full-time care and support, as cognitive decline is accompanied by physical deterioration. Complications such as infections, reduced mobility, and difficulty swallowing may significantly impact overall health and survival (Kumar et al., 2024).
Although the condition is progressive, early diagnosis, appropriate care planning, and supportive interventions can help individuals and families manage the condition more effectively and maintain quality of life for as long as possible.
Nutritional perspective in Alzheimer’s disease
Nutrition plays an important role in supporting brain health and overall wellbeing in individuals with Alzheimer’s disease. While dietary measures cannot cure the condition, maintaining a balanced and nutrient-rich diet may help support cognitive function, general health, and quality of life (NHS, 2024).
A diet rich in fruits, vegetables, whole grains, and healthy fats provides essential nutrients that support brain function. Antioxidants such as vitamins C and E may help reduce oxidative stress, which is believed to contribute to brain cell damage in neurodegenerative conditions (Mayo Clinic, 2024).
Healthy fats, particularly omega-3 fatty acids found in oily fish, nuts, and seeds, are associated with supporting brain structure and function. These nutrients may contribute to maintaining cognitive health and reducing inflammation (Cleveland Clinic, 2022).
Maintaining adequate hydration and regular meal patterns is also important, especially as individuals with Alzheimer’s disease may forget to eat or drink. Caregivers may need to support meal planning and ensure sufficient intake to prevent malnutrition and dehydration (NHS, 2024).
As the disease progresses, individuals may experience difficulty swallowing or reduced appetite, which can increase the risk of weight loss and nutritional deficiencies. In such cases, dietary modifications, such as softer foods or assisted feeding, may be required to ensure adequate nutrition (Kumar et al., 2024).
Psychological perspective in Alzheimer’s disease
Alzheimer’s disease has profound psychological and emotional impacts on both the individual and their caregivers. As cognitive abilities decline, individuals may experience confusion, frustration, anxiety, and changes in mood, particularly in the early and middle stages when they are aware of their difficulties (NHS, 2024).
One of the most common psychological effects is memory-related distress, where individuals become anxious or upset due to forgetfulness and difficulty recognising people or surroundings. This can lead to reduced confidence, social withdrawal, and a sense of loss of independence (Mayo Clinic, 2024).
As the disease progresses, individuals may develop behavioural and psychological symptoms of dementia (BPSD), including agitation, irritability, depression, sleep disturbances, and, in some cases, hallucinations or delusions. These symptoms can fluctuate and may be influenced by environmental factors or unmet needs (Alzheimer’s Association, 2025).
The emotional impact extends to caregivers and family members, who may experience stress, emotional burden, and burnout while providing ongoing support. Managing behavioural changes and increasing care needs can be challenging and may require psychological support and coping strategies (Kumar et al., 2024).
Supportive approaches such as maintaining familiar routines, providing reassurance, creating a calm environment, and encouraging social engagement where possible can help reduce distress and improve emotional wellbeing. Psychological support and education for both individuals and caregivers are essential components of holistic care.
Homeopathic perspective in Alzheimer’s disease
From a homeopathic perspective, Alzheimer’s disease is viewed as a condition involving a gradual decline in the body’s cognitive and neurological functioning, reflecting deeper disturbances in overall vitality and systemic balance. Homeopathy approaches such conditions through a holistic and individualised framework, considering the person as a whole rather than focusing solely on cognitive symptoms.
In homeopathic practice, emphasis is placed on understanding the individual’s unique symptom picture, including memory patterns, emotional responses, behavioural changes, sleep disturbances, and general physical health. Each individual may present differently, and remedy selection is guided by these personalised characteristics rather than the diagnosis alone.
Changes in cognition, mood, and behaviour are considered alongside factors such as life history, stress responses, and constitutional tendencies, recognising that mental and emotional aspects are closely linked with physical health. The aim is to support the individual’s overall functioning and adaptability within their current state of health.
Homeopathic care often focuses on promoting balance, comfort, and quality of life, particularly as the condition progresses. Attention may also be given to maintaining routine, reducing distress, and supporting emotional wellbeing, both for the individual and their caregivers.
Within this approach, care is centred on supporting the individual holistically, with consideration given to physical, emotional, and environmental factors that may influence their overall wellbeing.
Summary
Alzheimer’s disease is a progressive neurodegenerative disorder and the most common cause of dementia, characterised by a gradual decline in memory, thinking, behaviour, and the ability to perform daily activities. The condition develops over time due to complex changes in the brain, including the accumulation of abnormal proteins that disrupt normal brain function.
Symptoms typically begin with mild memory loss and progress to significant cognitive impairment, affecting communication, decision-making, and independence. As the disease advances, individuals may require increasing levels of care and support due to both cognitive and physical decline.
The development of Alzheimer’s disease is influenced by a combination of age, genetic factors, lifestyle, and overall health, with age being the most significant risk factor. While there is currently no cure, early recognition and appropriate management can help support quality of life and slow functional decline.
A comprehensive approach to care includes attention to nutritional support, psychological wellbeing, and a structured environment, alongside supportive and person-centred strategies. Holistic care aims to maintain dignity, comfort, and overall wellbeing for individuals living with Alzheimer’s disease, while also supporting caregivers.
Understanding the progression, impact, and management of Alzheimer’s disease is essential for providing effective, compassionate, and integrated care.
Practitioner CPD Reflective Practice
Alzheimer’s Disease: A Holistic and Integrative Perspective
This article offers a comprehensive overview of Alzheimer’s disease, highlighting its progressive nature, multifactorial causes, and the profound impact it has on individuals and their families. As complementary health practitioners, it invites us to reflect not only on clinical understanding but also on the depth of compassionate, person-centred care required in supporting those living with cognitive decline.
Key Learning Reflections
- Alzheimer’s disease is not simply a condition of memory loss, but a complex neurodegenerative disorder affecting cognition, behaviour, emotional wellbeing, and physical functioning.
- The condition develops over time due to a combination of genetic, biological, and lifestyle factors, reinforcing the importance of a whole-person, preventative and supportive approach.
- Nutrition, psychological support, and environmental stability all play essential roles in maintaining quality of life, even though the condition itself is not currently curable.
- The emotional and psychological burden on caregivers is significant, highlighting the need for family-inclusive, compassionate care strategies.
- A homeopathic and holistic perspective reminds us to treat the individual, not the diagnosis, considering emotional patterns, lifestyle, and personal history alongside physical symptoms.
Reflective Questions for Practice
- How confident do I feel in recognising the early signs of cognitive decline, and what steps could I take to improve my awareness?
- In what ways can I adapt my communication style to better support clients experiencing memory loss or confusion?
- How can I integrate nutritional, lifestyle, and emotional support strategies into my practice when working with clients at risk of, or living with, Alzheimer’s disease?
- Am I adequately considering the needs of caregivers, and how might I support them more effectively within my professional role?
- How does my current practice align with a truly holistic approach when managing chronic, progressive conditions such as Alzheimer’s disease?
Clinical Application
Practitioners can apply the insights from this article by:
- Supporting clients with brain-healthy lifestyle strategies, including balanced nutrition, physical activity, and mental stimulation
- Creating clear, calm, and supportive environments during consultations
- Encouraging routine and familiarity, which can reduce anxiety and confusion
- Working collaboratively with other healthcare providers where appropriate
- Offering emotional reassurance and continuity of care to both clients and their families
CPD Action Step
Identify one area of your current practice where you can enhance your support for clients with cognitive decline (e.g. communication, nutrition, caregiver support). Implement a small, measurable change over the next 4 weeks and reflect on its impact.
CPD Value: 1 Hour
You may log this activity in your CMA Member Portal as part of your annual CPD requirement.
References
Alzheimer’s Association. (2025). What Is Alzheimer’s Disease? Alzheimer’s Association. https://www.alz.org/alzheimers-dementia/what-is-alzheimers
Cleveland Clinic. (2022, December 10). Alzheimer’s disease. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/9164-alzheimers-disease
Mayo Clinic. (2024, November 8). Alzheimer’s disease. Mayo Clinic; Mayo Foundation for Medical Education and Research (MFMER). https://www.mayoclinic.org/diseases-conditions/alzheimers-disease/symptoms-causes/syc-20350447
NHS. (2024, July 4). Alzheimer’s Disease. NHS; NHS. https://www.nhs.uk/conditions/alzheimers-disease/
Kumar, A., Tsao, J. W., Sidhu, J., & Goyal, A. (2024, February 12). Alzheimer Disease. National Library of Medicine; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK499922/
Further Reading
Learn more about the ways that complementary medical and integrative health approaches can support people with a variety of conditions in The CMA’s “Conditions” library here.
Image Description
Alzheimer’s Disease Saggital brain image showing Alzzheimer related atrophy with cortical thinning and enlarged ventricles highlighting neurodegeneration and brain changes.
About the Author
Amrita Singh is a qualified Homoeopath, Psychologist, and Nutritionist with a strong multidisciplinary foundation in mind–body health. She holds an MSc in Psychology (UK) and an MSc in Food, Nutrition & Dietetics (India), alongside formal training in classical homoeopathy from the Central College of Homoeopathy, London. She is currently pursuing postgraduate studies with the Irish School of Homoeopathy.
A full member of the Complementary Medical Association (MCMA), Homoeopathy International (R. Hom. Int.), the British Psychological Society (Graduate Member), and Balen’s insured, Amrita integrates emotional insight, nutritional balance, and gentle homoeopathic care in her clinical approach.
Formerly the Head of Department at RMCH&RC, she now works with clients internationally & runs two physical clinics (Meerut City, Uttar Pradesh & Ambala Cantt., Haryana) in India, offering compassionate, holistic guidance that honours the interconnectedness of emotional wellbeing, physical health, and lifestyle patterns.
Contact & Credentials
Amrita Singh
Homoeopath, Psychologist & Nutritionist
Dip. CCH (England) | MSc Psychology (England) | MSc Food, Nutrition & Dietetics (India)
MCMA | R. Hom. Int. (Balen’s Insured) | GMBPsS
📧 [email protected]
🌐 https://amritasingh.co.uk/
📍 United Kingdom
Instagram – https://www.instagram.com/clinic_uk_2025/Facebook – https://www.facebook.com/profile.php?id=61582871564526